NSDL Q3 Profit Rises Nearly 30% To Rs 86 Crore
National Securities Depository Ltd. reported its financial performance for the third quarter of the fiscal year, with net profit rising 29.8% year-on-year to Rs 85.80 crore from Rs 66.09 crore in the same period last year.
Total income for the Mumbai-based depository increased by 16.2% to Rs 391.21 crore, compared to Rs 336.66 crore in the corresponding quarter of the previous year.
NSDL Q3 Highlights (Consolidated, YoY)
Total income up 16.2% to Rs 391.21 crore versus Rs 336.66 crore.
Net profit after tax up 29.8% to Rs 85.80 crore versus Rs 66.09 crore.
The earnings report comes as NSDL moves forward with its plans for an initial public offering. The Securities and Exchange Board of India granted approval for the company's IPO on Oct. 8, 2024. The public issue will consist solely of an offer for sale component, meaning existing shareholders will divest their holdings, with no fresh equity being issued.
SEBI issued an observation letter on Sept. 30, signalling its approval for the public offering. In its draft red herring prospectus filed in July 2023, NSDL stated it would offer up to 5.72 crore equity shares with a face value of Rs 2 per share.
ICICI Securities Ltd. is the lead book-running manager for the IPO, along with Axis Capital Ltd., SBI Capital Markets Ltd., HDFC Bank Ltd., HSBC Securities and Capital Markets (India) Pvt. Ltd., Motilal Oswal Investment Advisors Ltd., and IDBI Capital Markets & Securities Ltd.
NSDL is India's largest depository, measured by multiple parameters, including the number of issuers, active instruments, market share in demat settlement volume, and the value of assets under custody, as of March 31, 2023.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
